Autonomic regulation of insulin secretion is changed by pentobarbital in mice

Neuroscience Letters

Volumn 479, Issue 1, 2010, Pages 6-9

  Lee, Kung Shing ^a,b   Yu, Wen Jen ^c   Wang, Mei Jen ^c   Wu, Hung Tsung ^d   Chang, Chin Hong ^e   Cheng, Juei Tang ^d,e  

^a KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c HUNGKUANG UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Ginseng; Guanethidine; Insulin; Insulin secretion; Mice; Pentobarbital

Indexed keywords

ATROPINE; GINSENG EXTRACT; GLUCOSE; GUANETHIDINE; INSULIN; MUSCARINIC RECEPTOR; PENTOBARBITAL; STREPTOZOCIN; ANTIDIABETIC AGENT; CENTRAL DEPRESSANT AGENT; GLUCOSE BLOOD LEVEL; PLANT MEDICINAL PRODUCT;

ANESTHESIA MECHANISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTONOMIC INNERVATION; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CONCENTRATION RESPONSE; CONSCIOUSNESS; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOMEOSTASIS; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PARASYMPATHETIC TONE; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; SYMPATHETIC TONE; ANALYSIS; ANESTHESIA; ANIMAL; AUTONOMIC NERVOUS SYSTEM; C57BL MOUSE; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; METABOLISM; PANAX; PHYSIOLOGY; SECRETION (PROCESS); SPECIES DIFFERENCE;

ADJUVANTS, ANESTHESIA; ANESTHESIA; ANIMALS; AUTONOMIC NERVOUS SYSTEM; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; HOMEOSTASIS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PANAX; PENTOBARBITAL; PLANT PREPARATIONS; SPECIES SPECIFICITY;

EID: 77953696685     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.05.015     Document Type: Article

References (22)

1. Benarroch E.E., Zollman P.J., Schmelzer J.D., Nelson D.K., Low P.A. Guanethidine sympathectomy increases substance P concentration in the superior sympathetic ganglion of adult rats. Brain Res. 1992, 584:305-308.
2. Bourgeois J.M., Sassine A., Macabies J. Persistance of insulin secretion in hyperglycemia induced with urethane. C. R. Seances Soc. Biol. Fil. 1970, 164:2341-2345.
3. Chatzigeorgiou A., Halapas A., Kalafatakis K., Kamper E. The use of animal models in the study of diabetes mellitus. In Vivo 2009, 23:245-258.
4. Cherksey B., Mendelsohn S., Zadunaisky J., Altszuler N. Displacement of alpha- and beta-radioligands by specific adrenergic agonists in rat pancreatic islets. Pharmacology 1983, 27:95-102.
5. Doyle M.E., Egan J.M. Pharmacological agents that directly modulate insulin secretion. Pharmacol. Rev. 2003, 55:105-131.
6. Egan B.M. Insulin resistance and the sympathetic nervous system. Curr. Hypertens. Rep. 2003, 5:247-254.
7. Fyles J.M., Cawthorne M.A., Howell S.L. The characteristics of beta-adrenergic binding sites on pancreatic islets of Langerhans. J. Endocrinol. 1986, 111:263-270.
8. Gautam D., Gavrilova O., Jeon J., Pack S., Jou W., Cui Y., Li J.H., Wess J. Beneficial metabolic effects of M3 muscarinic acetylcholine receptor deficiency. Cell Metab. 2006, 4:363-375.
9. Grassi G., Dell'Oro R., Quarti-Trevano F., Scopelliti F., Seravalle G., Paleari F., Gamba P.L., Mancia G. Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia 2005, 48:1359-1365.
10. Havel P.J., Paquette T.L., Taborsky G.J. Halothane is less suppressive than pentobarbital on reflex and neural activation of pancreatic F-cell. Am. J. Physiol. 1986, 251:E111-116.
11. Ho I.K., Harris R.A. Mechanism of action of barbiturates. Annu. Rev. Pharmacol. Toxicol. 1981, 21:83-111.
12. Huggett R.J., Burns J., Mackintosh A.F., Mary D.A. Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension 2004, 44:847-852.
13. Kazerani H.R., Furman B.L. Comparison of urethane/chloralose and pentobarbitone anaesthesia for examining effects of bacterial lipopolysaccharide in mice. Fundam. Clin. Pharmacol. 2006, 20:379-384.
14. Krzemien K., Lipowska-Zabawska L. Urethane-induced hyperglycemia in rats. Acta Physiol. Pol. 1976, 27:369-376.
15. Lai D.M., Tu Y.K., Liu I.M., Chen P.F., Cheng J.T. Mediation of beta-endorphin by ginsenoside Rh2 to lower plasma glucose in streptozotocin-induced diabetic rats. Planta Med. 2006, 72:9-13.
16. Lake K.D., Martin B.R., Kunos G., Varga K. Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats. Hypertension 1997, 29:1204-1210.
17. Lee W.K., Kao S.T., Liu I.M., Cheng J.T. Increase of insulin secretion by ginsenoside Rh2 to lower plasma glucose in Wistar rats. Clin. Exp. Pharmacol. Physiol. 2006, 33:27-32.
18. Liu K.Y., Wu Y.C., Liu I.M., Yu W.C., Cheng J.T. Release of acetylcholine by syringin, an active principle of Eleutherococcus senticosus, to raise insulin secretion in Wistar rats. Neurosci. Lett. 2008, 434:195-199.
19. Niu H.S, Hsu F.L., Liu I.M. Role of sympathetic tone in the loss of syringin-induced plasma glucose lowering action in conscious Wistar rats. Neurosci. Lett. 2008, 445:113-116.
20. Stumvoll M., Goldstein B.J., van Haeften T.W. Pathogenesis of type 2 diabetes. Endocr. Res. 2007, 32:19-37.
21. Wang M.Y., Ren L.M., Du Z.J., Fu S.X. Urethane-induced hyperglycemia. Acta Pharmacol. Sin. 2000, 21:271-275.
22. Zhang R.J., Qian J.K., Yang G.H., Wang B.Z., Wen X.L. Medicinal protection with Chinese herb-compound against radiation damage. Aviat. Space Environ. Med. 1990, 61:729-731.